Cargando…
Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo
The delivery of anticancer agents to their subcellular sites of action is a significant challenge for effective cancer therapy. Peptides, which are integral to several oncogenic pathways, have significant potential to be utilised as cancer therapeutics due to their selectivity, high potency and lack...
Autores principales: | Haggag, Yusuf A., Matchett, Kyle B., Falconer, Robert A., Isreb, Mohammad, Jones, Jason, Faheem, Ahmed, McCarron, Paul, El-Tanani, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406988/ https://www.ncbi.nlm.nih.gov/pubmed/30769871 http://dx.doi.org/10.3390/cancers11020222 |
Ejemplares similares
-
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells
por: Sharma, Ankur, et al.
Publicado: (2018) -
Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
por: Yuen, Hiu-Fung, et al.
Publicado: (2016) -
Nanoencapsulation of sophorolipids in PEGylated poly(lactide-co-glycolide) as a novel approach to target colon carcinoma in the murine model
por: Haggag, Yusuf, et al.
Publicado: (2020) -
A mechanism of coupling RCC1 mobility to RanGTP production on the chromatin in vivo
por: Li, Hoi Yeung, et al.
Publicado: (2003) -
RanBP1 controls the Ran pathway in mammalian cells through regulation of mitotic RCC1 dynamics
por: Yau, Ka Chun, et al.
Publicado: (2020)